|
Originally Posted by RebelDarlin
As for the poppy seeds, I did ask about that since I had a bagel with poppy seeds a couple days before. I was told that the amount you would have to eat to have it show up is ridiculously large and it would probably NEVER happen.
Rebel kc0iv |
Maybe they should educate the people DOING the tests.
|
thanks..
everyone for the GREAT opinions/information!!!!
|
Originally Posted by RebelDarlin
Maybe they should educate the people DOING the tests.
kc0iv |
1. Cannabinoids (marijuana, hashish)
2. Cocaine (cocaine, benzoylecognine, cocaethylene) 3. Amphetamines (amphetamine, methamphetamine) 4. Opiates (heroin, opium, codeine, morphine) 5. Phencyclidine (PCP) These are the things they look for, all are controlled substances or illegal. You can take ANY over the counter drug and it will not show up as a positive for any of these drugs. |
more detail......
The NIDA 5 Drug testing in the United States began in the late 1980s with the testing of certain federal employees and specified DOT regulated occupations. Drug testing guidelines and processes, in these areas exclusively, are established and regulated (by the Substance Abuse and Mental Health Services Administration or SAMHSA, formerly under the direction of the National Institute on Drug Abuse or NIDA) require that companies who use professional drivers, specified safety sensitive transportation and/or oil and gas related occupations, and certain federal employers, test them for the presence of certain drugs. These test classes were established decades ago, and include five specific drug groups. They do not account for current drug usage patterns. For example, the tests do not include semi-synthetic opioids, such as oxycodone, oxymorphone, hydrocodone, hydromorphone, etc., compounds that are highly abused in America: 1. Cannabinoids (marijuana, hashish) 2. Cocaine (cocaine, benzoylecognine, cocaethylene) 3. Amphetamines (amphetamine, methamphetamine) 4. Opiates (heroin, opium, codeine, morphine) 5. Phencyclidine (PCP) While SAMHSA/NIDA guidelines only allow labs to report quantitative results for the "NIDA-5" on their official NIDA tests, many drug testing labs and on-site tests also offer a wider or "more appropriate" set of drug screens which are more reflective of current drug abuse patterns. As noted above, these tests include synthetic pain killers such as Oxycodone, Oxymorphone, Hydrocodone, Hydromorphone, benzodiazepines (Valium, Xanax, Klonopin, Restoril) and barbiturates in other drug panels (a "panel" is a predetermined list of tests to run). The confirmation test (usually GCMS) can tell the difference between chemically similar drugs such as methamphetamine and ecstasy, and in the absence of detectable amounts of methamphetamine in the sample, the lab will either report the sample as negative or report it as positive for MDMA. What the lab reports to the client depends upon whether MDMA was included in the panel as something to be tested for. Gamma-hydroxy-butyrate (GHB) was not routinely tested for in the early 1990s, but due to increasing use, some labs have added it as an optional test. GHB is rare in pre-employment screening, but is commonly checked for in suspected cases of drug overdose, date rape, and post-mortem toxicology tests. Ketamine (Special K) may or may not be tested for, depending upon the preferences of the entity paying for the test, though testing for it is uncommon. In general, the greater the number of drugs tested for, the higher the price of the test, so many employers stick to the NIDA 5 for financial reasons. Other drugs, such as meperidine (Demerol), fentanyl, propoxyphene, and methadone are not commonly tested for in most pre-employment situations. These drugs are more likely to be included in tests for certain demographic groups (such as healthcare workers, drug rehab patients, etc.) Hallucinogens other than cannabis and PCP, such as mushrooms (psilocybin), LSD, and peyote (mescaline) are rarely tested for. |
DOT drug testing uses the split specimen system. Several drugs may cause a positive on the initial test but the second spit speciman actually determines what the drug is.
|
Originally Posted by meanbone79
DOT drug testing uses the split specimen system. Several drugs may cause a positive on the initial test but the second spit speciman actually determines what the drug is.
See: http://www.fmcsa.dot.gov/rules-regul...csr/40.153.htm about your right for "split specimen" testing. kc0iv |
Originally Posted by kc0iv
Originally Posted by meanbone79
DOT drug testing uses the split specimen system. Several drugs may cause a positive on the initial test but the second spit speciman actually determines what the drug is.
See: http://www.fmcsa.dot.gov/rules-regul...csr/40.153.htm about your right for "split specimen" testing. kc0iv |
Originally Posted by Fredog
Originally Posted by kc0iv
Originally Posted by meanbone79
DOT drug testing uses the split specimen system. Several drugs may cause a positive on the initial test but the second spit speciman actually determines what the drug is.
See: http://www.fmcsa.dot.gov/rules-regul...csr/40.153.htm about your right for "split specimen" testing. kc0iv § 40.71 How does the collector prepare the specimens? (a) All collections under DOT agency drug testing regulations must be split specimen collections. (b) As the collector, you must take the following steps, in order, after the employee brings the urine specimen to you. You must take these steps in the presence of the employee. (1) Check the box on the CCF (Step 2) indicating that this was a split specimen collection. (2) You, not the employee, must first pour at least 30 mL of urine from the collection container into one specimen bottle, to be used for the primary specimen. (3) You, not the employee, must then pour at least 15 mL of urine from the collection container into the second specimen bottle to be used for the split specimen. (4) You, not the employee, must place and secure (i.e., tighten or snap) the lids/caps on the bottles. (5) You, not the employee, must seal the bottles by placing the tamper-evident bottle seals over the bottle caps/lids and down the sides of the bottles. (6) You, not the employee, must then write the date on the tamper-evident bottle seals. (7) You must then ensure that the employee initials the tamper-evident bottle seals for the purpose of certifying that the bottles contain the specimens he or she provided. If the employee fails or refuses to do so, you must note this in the “Remarks” line of the CCF (Step 2) and complete the collection process. (8 ) You must discard any urine left over in the collection container after both specimen bottles have been appropriately filled and sealed. There is one exception to this requirement: you may use excess urine to conduct clinical tests (e.g., protein, glucose) if the collection was conducted in conjunction with a physical examination required by a DOT agency regulation. Neither you nor anyone else may conduct further testing (such as adulteration testing) on this excess urine and the employee has no legal right to demand that the excess urine be turned over to the employee. However, as I said before the "split specimen" is not used for the standard test. The "split specimen" is used when an employee request the MRO perform a retest because of a failed drug test. See: 40.3 What do the terms used in this regulation mean? "Split specimen. In drug testing, a part of the urine specimen that is sent to a first laboratory and retained unopened, and which is transported to a second laboratory in the event that the employee requests that it be tested following a verified positive test of the primary specimen or a verified adulterated or substituted test result. As you can see the is only one exception to the rule that being ( 8 ). kc0iv |
| All times are GMT -12. The time now is 09:24 PM. |
Copyright © 2026 MH Sub I, LLC dba Internet Brands. All rights reserved